A detailed history of Processus Wealth & Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Processus Wealth & Capital Management, LLC holds 8,923 shares of AMGN stock, worth $2.62 Million. This represents 2.37% of its overall portfolio holdings.

Number of Shares
8,923
Previous 9,882 9.7%
Holding current value
$2.62 Million
Previous $3.09 Billion 6.89%
% of portfolio
2.37%
Previous 2.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$309.38 - $337.38 $296,695 - $323,547
-959 Reduced 9.7%
8,923 $2.88 Billion
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $32,318 - $39,275
123 Added 1.26%
9,882 $3.09 Billion
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $347,648 - $419,656
1,293 Added 15.27%
9,759 $2.77 Billion
Q4 2023

Mar 05, 2024

BUY
$255.7 - $288.46 $2.16 Million - $2.44 Million
8,466 New
8,466 $2.44 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Processus Wealth & Capital Management, LLC Portfolio

Follow Processus Wealth & Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Processus Wealth & Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Processus Wealth & Capital Management, LLC with notifications on news.